EW

Edwards Lifesciences Corp (EW) Stock Price

Closed
EW
$101.59
-$2.07(-1.99%)

Content updated: 2026-11-22 21:51:44

Yesterday's Close
$103.66
Today's Open
$103.56
Today's High
$104.73
Today's Low
$101.57
Volume
12.17M shares
52-Week Range
$76.48-$108.56

As of 2026-11-22 21:51:44, Edwards Lifesciences Corp (EW) was quoted at $101.59, a change of -$2.07 (-1.99%) from the previous close. The day's range was $101.57–$104.73, and the 52-week range was $76.48–$108.56.

Why Is Edwards Lifesciences Corp (EW) Stock Falling?

AI Stock Price Analysis

Content updated: 2026-11-20 21:47:41

EW faded from an intraday high of $104.91 to $101.84 at the cut-off, down 1.98% from the prior close and near the session low, on light full-day volume. The recent fundamental backdrop is a third-quarter beat and a third 2026 guidance raise.

Past 1W-4.82%Period Low $101.66Period High $108.00
Past 1M+14.89%Period Low $87.90Period High $108.00
Past 3M+13.30%Period Low $82.42Period High $108.00
Past 1Y+20.69%Period Low $74.66Period High $108.00

About Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Ticker / Exchanges
EW / NYSE
Industry / Sector
Medical - Devices / Healthcare
CEO
Bernard J. Zovighian
Headquarters
Irvine,CA,US
Official Website
https://www.edwards.com
Listing Date
2000-03-27

Recent Company Events

  • 2027-02-09
    Earnings Report · ExpectedOn 2027-02-09, the 2026/Q4 earnings report is expected to be released.

Edwards Lifesciences Corp (EW) Derivatives Trading

Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

Edwards Lifesciences Corp (EW) Company Financials

Valuation and Shares

Market Cap
$58.55B
P/E Ratio (TTM)
57.54
P/B Ratio
5.39
Shares Outstanding
575.00M shares
Float Shares
573.23M shares
Dividend Yield (TTM)
0.00%

Latest Reported Financials

2026 Q3 Financials

Report Release Date: 2026-11-04

Operating Revenue (Actual)

$1.71B

Same Period Last Year: +10.46%

Earnings per Share (Actual)

$0.80

Same Period Last Year: +19.40%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$4.46B$5.01B$5.44B$6.06B
Net Profit$1.52B$1.40B$4.17B$1.07B
Operating Cash Flow$1.21B$896.00M$542.00M$1.59B

EW FAQ

What is the current stock price of Edwards Lifesciences Corp (EW)?

x
As of 2026-11-22 21:51 (UTC+8), the latest available quote for Edwards Lifesciences Corp (EW) is $101.59 USD, with a change of -$2.07 USD (-1.99%) from the previous trading day's close. Current market status: Closed.

Which exchange is EW listed on?

x

How has Edwards Lifesciences Corp stock performed over the past month?

x

What is the market cap of Edwards Lifesciences Corp?

x

What are Edwards Lifesciences Corp's latest financial results?

x

What factors may affect the stock price of Edwards Lifesciences Corp (EW)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.